Delfi Diagnostics logo

Delfi Diagnostics

Baltimore, MD

Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.

delfidiagnostics.com

Company Details

Founded

2019

Employees

Between 100 - 200 employees

Raised

$330,500,000

Headquarters Location

Baltimore, MD

Public

No

Acquired

No

CEO

Victor VelculescuVictor Velculescu

Founders

Victor Velculescu
Victor Velculescu
Alessandro Leal
Nicholas Dracopoli
Nicholas Dracopoli
Robert Scharpf

Company Collections

These are collections Delfi Diagnostics is a part of. Click on the collection name to view similar companies.

Delfi Diagnostics' Investors

Current Job Listings

Listing 0 of 4 job openings

    Delfi Diagnostics Headquarters Location

    1812 Ashland Avenue, Baltimore, MD 21205

    Total Amount Raised: $330,500,000

    Delfi Diagnostics' Investors

    Delfi Diagnostics Funding Rounds

    • Series B

      $225,000,000

      Series B Investors

      DFJ Growth
      Samsara BioCapital
      Eli Lilly and Company
      AV8 Ventures
      Point72
      Menlo Ventures
      Illumina Ventures
      Open Field Capital
      Windham Venture Partners
      T. Rowe Price
      Rock Springs Capital
      OrbiMed Advisors
      Point Field Partners
      Foresite Capital
      Cowen Healthcare Investments
      Brown Advisory
      OUP (Osage University Partners)
      Northpond Ventures
      PTX Capital
      Initiate Ventures
    • Series A

      $100,000,000

      Series A Investors

      OrbiMed Advisors
      AV8 Ventures
      Windham Venture Partners
      Rock Springs Capital
      Menlo Ventures
      Samsara BioCapital
      Northpond Ventures
      T. Rowe Price
      OUP (Osage University Partners)
      Cowen Healthcare Investments
      Foresite Capital
      Illumina Ventures
    • Seed

      $5,500,000

      Seed Investors

      Menlo Ventures
      Illumina Ventures
      AV8 Ventures
      Windham Venture Partners
      Samsara BioCapital
    Funding info provided by Diffbot.

    Delfi Diagnostics Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Delfi Diagnostics.

    Recent reviews